AAAAAA

   
Results: 1-10 |
Results: 10
A COMPARISON BETWEEN CONTINUOUS-INFUSION VERSUS STANDARD BOLUS ADMINISTRATION OF HEPARIN BASED ON MONITORING IN CARDIAC-SURGERY
Authors: DESPOTIS GJ LEVINE V JOINERMAIER D JOIST JH
Citation: Gj. Despotis et al., A COMPARISON BETWEEN CONTINUOUS-INFUSION VERSUS STANDARD BOLUS ADMINISTRATION OF HEPARIN BASED ON MONITORING IN CARDIAC-SURGERY, Blood coagulation & fibrinolysis, 8(7), 1997, pp. 419-430
PAF-INDUCED WHOLE-BLOOD PROCOAGULANT ACTIVITY - EFFECTS OF PLATELETS,WHITE BLOOD-CELLS AND REOPRO(TM)
Authors: DESPOTIS GJ IKONOMAKOU S LEVINE V JOINERMAIER D SANTORO SA JOIST JH
Citation: Gj. Despotis et al., PAF-INDUCED WHOLE-BLOOD PROCOAGULANT ACTIVITY - EFFECTS OF PLATELETS,WHITE BLOOD-CELLS AND REOPRO(TM), Thrombosis and haemostasis, 1997, pp. 2692-2692
EFFECTS OF PLATELETS AND WHITE BLOOD-CELLS AND ANTIPLATELET AGENT C7E3 (REOPRO(TM)) ON A NEW TEST OF PAF PROCOAGULANT ACTIVITY OF WHOLE-BLOOD
Authors: DESPOTIS GJ IKONOMAKOU S LEVINE V JOINERMAIER D SANTORO SA JOIST JH
Citation: Gj. Despotis et al., EFFECTS OF PLATELETS AND WHITE BLOOD-CELLS AND ANTIPLATELET AGENT C7E3 (REOPRO(TM)) ON A NEW TEST OF PAF PROCOAGULANT ACTIVITY OF WHOLE-BLOOD, Thrombosis research, 86(3), 1997, pp. 205-219
ANTITHROMBIN-III DURING CARDIAC-SURGERY - EFFECT ON RESPONSE OF ACTIVATED CLOTTING TIME TO HEPARIN AND RELATIONSHIP TO MARKERS OF HEMOSTATIC ACTIVATION
Authors: DESPOTIS GJ LEVINE V JOIST JH JOINERMAIER D SPITZNAGEL E
Citation: Gj. Despotis et al., ANTITHROMBIN-III DURING CARDIAC-SURGERY - EFFECT ON RESPONSE OF ACTIVATED CLOTTING TIME TO HEPARIN AND RELATIONSHIP TO MARKERS OF HEMOSTATIC ACTIVATION, Anesthesia and analgesia, 85(3), 1997, pp. 498-506
HEMOFILTRATION DURING CARDIOPULMONARY BYPASS - THE EFFECT ON ANTI-XA AND ANTI-IIA HEPARIN ACTIVITY
Authors: DESPOTIS GJ LEVINE V FILOS KS JOINERMAIER D JOIST JH
Citation: Gj. Despotis et al., HEMOFILTRATION DURING CARDIOPULMONARY BYPASS - THE EFFECT ON ANTI-XA AND ANTI-IIA HEPARIN ACTIVITY, Anesthesia and analgesia, 84(3), 1997, pp. 479-483
MORE EFFECTIVE SUPPRESSION OF HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS UNDERGOING CARDIAC-SURGERY BY HEPARIN DOSING BASED ON HEPARIN BLOOD-CONCENTRATIONS RATHER THEN ACT
Authors: DESPOTIS GJ JOIST JH HOGUE CW ALSOUFIEV A JOINERMAIER D SANTORO SA SPITZNAGEL E WEITZ JI GOODNOUGH LT
Citation: Gj. Despotis et al., MORE EFFECTIVE SUPPRESSION OF HEMOSTATIC SYSTEM ACTIVATION IN PATIENTS UNDERGOING CARDIAC-SURGERY BY HEPARIN DOSING BASED ON HEPARIN BLOOD-CONCENTRATIONS RATHER THEN ACT, Thrombosis and haemostasis, 76(6), 1996, pp. 902-908
EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS
Authors: DESPOTIS GJ JOIST JH JOINERMAIER D ALSOUFIEV AL TRIANTAFILLOU AN GOODNOUGH LT SANTORO SA LAPPAS DG
Citation: Gj. Despotis et al., EFFECT OF APROTININ ON ACTIVATED CLOTTING TIME, WHOLE-BLOOD AND PLASMA HEPARIN MEASUREMENTS, The Annals of thoracic surgery, 59(1), 1995, pp. 106-111
THE EFFECT OF HIGHER HEPARIN CONCENTRATIONS ON PRESERVATION OF HEMOSTASIS IN CARDIAC SURGICAL PATIENTS
Authors: DESPOTIS GJ JOIST JH HOGUE CW ALSOUFIEV A JOINERMAIER D SPITZNAGEL E SANTORO SA GOODNOUGH LT
Citation: Gj. Despotis et al., THE EFFECT OF HIGHER HEPARIN CONCENTRATIONS ON PRESERVATION OF HEMOSTASIS IN CARDIAC SURGICAL PATIENTS, Anesthesiology, 83(3A), 1995, pp. 91-91
VARIABILITY OF HEPARIN SENSITIVITY OF COMMERCIALLY AVAILABLE APTT REAGENTS - IMPLICATIONS FOR THERAPEUTIC RANGE FOR HEPARIN-THERAPY
Authors: JOINERMAIER D CHANCE D JOIST JH
Citation: D. Joinermaier et al., VARIABILITY OF HEPARIN SENSITIVITY OF COMMERCIALLY AVAILABLE APTT REAGENTS - IMPLICATIONS FOR THERAPEUTIC RANGE FOR HEPARIN-THERAPY, Thrombosis and haemostasis, 69(6), 1993, pp. 1123-1123
VARIABILITY OF HEPARIN SENSITIVITY AND RESPONSIVENESS OF UNITED-STATES COMMERCIAL APTT REAGENTS - IMPLICATIONS FOR THERAPEUTIC RANGE FOR HEPARIN-THERAPY
Authors: JOINERMAIER D CHANCE D JOIST JH
Citation: D. Joinermaier et al., VARIABILITY OF HEPARIN SENSITIVITY AND RESPONSIVENESS OF UNITED-STATES COMMERCIAL APTT REAGENTS - IMPLICATIONS FOR THERAPEUTIC RANGE FOR HEPARIN-THERAPY, Blood, 82(10), 1993, pp. 10000410-10000410
Risultati: 1-10 |